Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Difan Zheng

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Thoracic Cancer|July 17, 2021
Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resectionXingxin Yao, Difan Zheng, Chongze Yuan, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2017
Clinical features and surgical outcomes of pulmonary artery sarcomaKanhua Yin, Zhiqi Zhang, Rongkui Luo, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancerXinghua Cheng, Difan Zheng, Yuan Li, et al.
Journal of Cancer Research and Clinical Oncology|March 14, 2018
Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomyYiyang Wang, Difan Zheng, Jiajie Zheng, et al.
International Journal of Cancer|August 29, 2018
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinomaShanbo Zheng, Xiaoyang Luo, Chuanpeng Dong, et al.
Cancer Medicine|May 27, 2016
Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosisShanbo Zheng, Rui Wang, Yang Zhang, et al.
Cancer Management and Research|December 28, 2020
Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell CarcinomaLingdun Zhuge, Binhao Huang, Juntao Xie, et al.
Translational Lung Cancer Research|June 24, 2021
Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictorsYiyang Wang, Difan Zheng, Jizhuang Luo, et al.
Journal of Thoracic Disease|June 11, 2019
Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patientsXiaoting Tao, Chongze Yuan, Difan Zheng, et al.
Oncotargets and Therapy|November 4, 2015
SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomasShanbo Zheng, Yunjian Pan, Rui Wang, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Thoracic Cancer|July 17, 2021
Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resectionXingxin Yao, Difan Zheng, Chongze Yuan, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 11, 2017
Clinical features and surgical outcomes of pulmonary artery sarcomaKanhua Yin, Zhiqi Zhang, Rongkui Luo, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancerXinghua Cheng, Difan Zheng, Yuan Li, et al.
Journal of Cancer Research and Clinical Oncology|March 14, 2018
Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomyYiyang Wang, Difan Zheng, Jiajie Zheng, et al.
International Journal of Cancer|August 29, 2018
A B7-CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinomaShanbo Zheng, Xiaoyang Luo, Chuanpeng Dong, et al.
Cancer Medicine|May 27, 2016
Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosisShanbo Zheng, Rui Wang, Yang Zhang, et al.
Cancer Management and Research|December 28, 2020
Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell CarcinomaLingdun Zhuge, Binhao Huang, Juntao Xie, et al.
Translational Lung Cancer Research|June 24, 2021
Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictorsYiyang Wang, Difan Zheng, Jizhuang Luo, et al.
Journal of Thoracic Disease|June 11, 2019
Outcomes comparison between neoadjuvant chemotherapy and adjuvant chemotherapy in stage IIIA non-small cell lung cancer patientsXiaoting Tao, Chongze Yuan, Difan Zheng, et al.
Oncotargets and Therapy|November 4, 2015
SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomasShanbo Zheng, Yunjian Pan, Rui Wang, et al.
Pageof 5